MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi.
Antibody reactivity (target): MiTF
Antibody type: Primary
Host species: Mouse
Clonality: Monoclonal
Clone: D5
Isotype: IgG1, kappa
Molecular weight: 52-56 kDa (doublet)
Synonyms: BHLHE32; Class E basic helix-loop-helix protein 32 (bHLHe32); CMM8; Mi; Microphthalmia-associated transcription factor; MITF; WS2; WS2A
Human gene symbol: MITF
Entrez gene ID: 4286
SwissProt: O75030
Unigene: 166017 & 618266
Immunogen: NH2 terminus fragment of human Mi protein
Antibody target cellular localization: Nucleus
Verified antibody applications: IHC (FFPE) (verified)
Species reactivity: Human
Shipping conditions: Room temperature
Storage Conditions: at 2 to 8 °C, Protect fluorescent conjugates from light, Note: store BSA-free antibodies at -10 to -35 °C
Shelf life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Regulatory status: For research use only (RUO)